BioSpace News Archive

Genetown

CARB-X funds Peptilogics to develop a new class of antibiotics to treat serious superbug infections associated with implants

Peptilogics’ engineered cationic antibiotic peptide is designed to kill multi-drug-resistant bacteria rapidly, transforming the way prosthetic joint infections (PJI) are treated

February 26, 2020

·

8 min read

Deals

Takeda Acquires Celiac-Focused PvP Biologics in Deal Worth $330 Million

Three years after Takeda and San Diego-based PvP Biologics inked a $35 million deal to develop a novel treatment for celiac disease, the Japanese pharma company has exercised its option to acquire the company for $330 million.

February 26, 2020

·

3 min read

·

Alex Keown

Bio NC

As Coronavirus Threat Continues, Biopharma and Academia Gear Up to Test and Develop Vaccines and Therapies

The U.S. Centers for Disease Control and Prevention warned the public yesterday to be prepared for it to spread in the U.S., indicating it was “when,” not “if.”

February 26, 2020

·

5 min read

·

Mark Terry

Bioactive Adrenomedullin, measured with sphingotec’s bio-ADM(R) assay plays a key role in septic shock patients as top-line results of AdrenOSS-2 Phase II Study indicate

Bioactive Adrenomedullin is a biomarker for endothelial dysfunction and allows the prediction of septic shock as elevated blood levels of bio-ADM(R) predict blood pressure break down and blood vessel leakage resulting in edema

February 26, 2020

·

7 min read

Drug Development

Novo Seeds Portfolio Company IO Biotech Announces Positive Outcome of Interim Analysis of Phase 2 Trial in First Line Non-small Cell Lung Cancer

Data position the company to start potential registrational trials with two drugs in two tumor types

February 26, 2020

·

5 min read

Genetown

Dana-Farber Cancer Institute and MPM Capital Announce $100 Million Cancer Fund

It will combine MPM’s venture capital investment fundraising with Dana-Farber’s philanthropic fundraising for cancer research.

February 26, 2020

·

2 min read

·

Mark Terry

Business

Wolfgang Kintzel to Become Cellbox Solutions’ CEO

Cellbox Solutions announces the expansion of its Board of Directors and the appointment of a new CEO - Wolfgang Kintzel will start as Chief Executive Officer effective March 1, 2020.

February 26, 2020

·

2 min read

Genetown

Alexion Discretely Discontinues Development of an Anti-FcRn Drug

The company has abandoned the project based on unfavorable early-stage data.

February 26, 2020

·

2 min read

·

Alex Keown

Biotech Beach

Report: Iovance Exploring Potential Sale of the Company

Shares of Iovance Biotherapeutics shot up Tuesday on rumors the company could be up for sale.

February 26, 2020

·

2 min read

·

Alex Keown

Drug Development

Judge Rules Decade Worth of Unreported Clinical Trial Data Must be Published

A federal judge has ruled that a decade’s worth of unpublished clinical trial data from drug companies, universities and other agencies involved, must now be made public.

February 26, 2020

·

2 min read

·

Alex Keown